Aditi Dhir

Clinical trials

• Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  Site PI · Recruiting · Phase 1

  H. Lee Moffitt Cancer Center and Research Institute

  2026–2030
• Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

  Site PI · Recruiting

  H. Lee Moffitt Cancer Center and Research Institute

  2024–2027
• A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

  Site PI · Recruiting · Phase 1, Phase 2

  Nationwide Children's Hospital

  2022–2027
• Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

  Site PI · Recruiting · Phase 3

  Children's Oncology Group

  2022–2030